The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat

N. E. Stagliano, W. Dalton Dietrich, R. Prado, E. J. Green, R. Busto

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Although nitric oxide (NO) has been shown to play an important role in the pathophysiology of cerebral ischemia, its contribution to the pathogenesis of experimentally induced thromboembolic stroke is unknown. In this study, we pharmacologically manipulated NO levels in the acute post- thrombotic stage and determined the effects on behavior and histopathology. The following drugs were used: nitro-L-arginine-methyl ester (L-NAME), a non- specific endothelial and neuronal nitric oxide synthase (eNOS and nNOS) inhibitor, 3-bromo-7-nitroindazole (7-NI), a specific inhibitor for nNOS, the NO precursor, exogenous L-arginine and the NO-donor, 3-morpholino-sydnonimine (SIN-1). Male Wistar rats (n = 76) were randomly assigned to receive vehicle or drug immediately after common carotid artery thrombosis (CCAT). Regional measurements of cortical NOS activity using the [3H]L-arginine to [3H]L- citrulline conversion assay were decreased I h after treatment with L-NAME and 7-NI by 50 and 65%, respectively; hippocampal NOS activity was reduced with L-NAME by 35% and with 7-NI by 65%. L-NAME significantly worsened forelimb placing as compared to other groups. 7-NI accelerated sensorimotor recovery. Water maze retention deficits were noted 48 h after CCAT and these were exacerbated by L-NAME treatment. Histopathological protection was conferred in the hippocampus by 7-NI and SIN-1; conversely, L-NAME increased neuronal injury in the contralateral cortex. L-arginine had no effect on these outcomes. In conclusion, both structural and functional consequences of CCAT can be aggravated by limiting endothelial NO production in the acutely post-thrombotic brain. In contrast, inhibition of nNOS and infusion of an NO donor has a beneficial effect on pathology.

Original languageEnglish
Pages (from-to)32-40
Number of pages9
JournalBrain Research
Volume759
Issue number1
DOIs
StatePublished - Jun 6 1997

Fingerprint

NG-Nitroarginine Methyl Ester
Nitric Oxide
Stroke
Carotid Artery Thrombosis
Arginine
Nitric Oxide Donors
Citrulline
Nitric Oxide Synthase Type I
Forelimb
Nitric Oxide Synthase Type III
Brain Ischemia
Pharmaceutical Preparations
Wistar Rats
Hippocampus
Pathology
7-nitroindazole
Water
Wounds and Injuries
Brain

Keywords

  • Behavior
  • Ischemia
  • Nitric oxide
  • Nitric oxide synthase inhibition
  • Rat
  • Stroke

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat. / Stagliano, N. E.; Dalton Dietrich, W.; Prado, R.; Green, E. J.; Busto, R.

In: Brain Research, Vol. 759, No. 1, 06.06.1997, p. 32-40.

Research output: Contribution to journalArticle

Stagliano, N. E. ; Dalton Dietrich, W. ; Prado, R. ; Green, E. J. ; Busto, R. / The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat. In: Brain Research. 1997 ; Vol. 759, No. 1. pp. 32-40.
@article{d597096fc8f2434eb653ac80e3abb14a,
title = "The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat",
abstract = "Although nitric oxide (NO) has been shown to play an important role in the pathophysiology of cerebral ischemia, its contribution to the pathogenesis of experimentally induced thromboembolic stroke is unknown. In this study, we pharmacologically manipulated NO levels in the acute post- thrombotic stage and determined the effects on behavior and histopathology. The following drugs were used: nitro-L-arginine-methyl ester (L-NAME), a non- specific endothelial and neuronal nitric oxide synthase (eNOS and nNOS) inhibitor, 3-bromo-7-nitroindazole (7-NI), a specific inhibitor for nNOS, the NO precursor, exogenous L-arginine and the NO-donor, 3-morpholino-sydnonimine (SIN-1). Male Wistar rats (n = 76) were randomly assigned to receive vehicle or drug immediately after common carotid artery thrombosis (CCAT). Regional measurements of cortical NOS activity using the [3H]L-arginine to [3H]L- citrulline conversion assay were decreased I h after treatment with L-NAME and 7-NI by 50 and 65{\%}, respectively; hippocampal NOS activity was reduced with L-NAME by 35{\%} and with 7-NI by 65{\%}. L-NAME significantly worsened forelimb placing as compared to other groups. 7-NI accelerated sensorimotor recovery. Water maze retention deficits were noted 48 h after CCAT and these were exacerbated by L-NAME treatment. Histopathological protection was conferred in the hippocampus by 7-NI and SIN-1; conversely, L-NAME increased neuronal injury in the contralateral cortex. L-arginine had no effect on these outcomes. In conclusion, both structural and functional consequences of CCAT can be aggravated by limiting endothelial NO production in the acutely post-thrombotic brain. In contrast, inhibition of nNOS and infusion of an NO donor has a beneficial effect on pathology.",
keywords = "Behavior, Ischemia, Nitric oxide, Nitric oxide synthase inhibition, Rat, Stroke",
author = "Stagliano, {N. E.} and {Dalton Dietrich}, W. and R. Prado and Green, {E. J.} and R. Busto",
year = "1997",
month = "6",
day = "6",
doi = "10.1016/S0006-8993(97)00200-X",
language = "English",
volume = "759",
pages = "32--40",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat

AU - Stagliano, N. E.

AU - Dalton Dietrich, W.

AU - Prado, R.

AU - Green, E. J.

AU - Busto, R.

PY - 1997/6/6

Y1 - 1997/6/6

N2 - Although nitric oxide (NO) has been shown to play an important role in the pathophysiology of cerebral ischemia, its contribution to the pathogenesis of experimentally induced thromboembolic stroke is unknown. In this study, we pharmacologically manipulated NO levels in the acute post- thrombotic stage and determined the effects on behavior and histopathology. The following drugs were used: nitro-L-arginine-methyl ester (L-NAME), a non- specific endothelial and neuronal nitric oxide synthase (eNOS and nNOS) inhibitor, 3-bromo-7-nitroindazole (7-NI), a specific inhibitor for nNOS, the NO precursor, exogenous L-arginine and the NO-donor, 3-morpholino-sydnonimine (SIN-1). Male Wistar rats (n = 76) were randomly assigned to receive vehicle or drug immediately after common carotid artery thrombosis (CCAT). Regional measurements of cortical NOS activity using the [3H]L-arginine to [3H]L- citrulline conversion assay were decreased I h after treatment with L-NAME and 7-NI by 50 and 65%, respectively; hippocampal NOS activity was reduced with L-NAME by 35% and with 7-NI by 65%. L-NAME significantly worsened forelimb placing as compared to other groups. 7-NI accelerated sensorimotor recovery. Water maze retention deficits were noted 48 h after CCAT and these were exacerbated by L-NAME treatment. Histopathological protection was conferred in the hippocampus by 7-NI and SIN-1; conversely, L-NAME increased neuronal injury in the contralateral cortex. L-arginine had no effect on these outcomes. In conclusion, both structural and functional consequences of CCAT can be aggravated by limiting endothelial NO production in the acutely post-thrombotic brain. In contrast, inhibition of nNOS and infusion of an NO donor has a beneficial effect on pathology.

AB - Although nitric oxide (NO) has been shown to play an important role in the pathophysiology of cerebral ischemia, its contribution to the pathogenesis of experimentally induced thromboembolic stroke is unknown. In this study, we pharmacologically manipulated NO levels in the acute post- thrombotic stage and determined the effects on behavior and histopathology. The following drugs were used: nitro-L-arginine-methyl ester (L-NAME), a non- specific endothelial and neuronal nitric oxide synthase (eNOS and nNOS) inhibitor, 3-bromo-7-nitroindazole (7-NI), a specific inhibitor for nNOS, the NO precursor, exogenous L-arginine and the NO-donor, 3-morpholino-sydnonimine (SIN-1). Male Wistar rats (n = 76) were randomly assigned to receive vehicle or drug immediately after common carotid artery thrombosis (CCAT). Regional measurements of cortical NOS activity using the [3H]L-arginine to [3H]L- citrulline conversion assay were decreased I h after treatment with L-NAME and 7-NI by 50 and 65%, respectively; hippocampal NOS activity was reduced with L-NAME by 35% and with 7-NI by 65%. L-NAME significantly worsened forelimb placing as compared to other groups. 7-NI accelerated sensorimotor recovery. Water maze retention deficits were noted 48 h after CCAT and these were exacerbated by L-NAME treatment. Histopathological protection was conferred in the hippocampus by 7-NI and SIN-1; conversely, L-NAME increased neuronal injury in the contralateral cortex. L-arginine had no effect on these outcomes. In conclusion, both structural and functional consequences of CCAT can be aggravated by limiting endothelial NO production in the acutely post-thrombotic brain. In contrast, inhibition of nNOS and infusion of an NO donor has a beneficial effect on pathology.

KW - Behavior

KW - Ischemia

KW - Nitric oxide

KW - Nitric oxide synthase inhibition

KW - Rat

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0030805143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030805143&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(97)00200-X

DO - 10.1016/S0006-8993(97)00200-X

M3 - Article

VL - 759

SP - 32

EP - 40

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -